C. Nicklaus Steussy

C. Nicklaus Steussy

Auto-generated profile, based on publicly available information

C. Nicklaus Steussy

Department of Biological Sciences, Purdue University, West Lafayette, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2016 in Plant Physiology
Verified
Journal Article
Open access
PDF file
PRPhillip S. Rushton
Phillip S. Rushton
AOAnna T. Olek
Anna T. Olek
LMLee Makowski
Lee Makowski
JBJohn Badger
John Badger
CSC. Nicklaus Steussy
C. Nicklaus Steussy
CSCynthia V. Stauffacher
Cynthia V. Stauffacher
The crystal structure of a rice CesA8 plant-conserved region (P-CR), solved to 2.4 Å resolution, is dockedto a model of the catalytic domain of CesA8 using SAXS

3 April 2023 in Communications Biology
Verified
Journal Article
Open access
PDF file
SBSucharita Bose
Sucharita Bose
CSC. Nicklaus Steussy
C. Nicklaus Steussy
DLDaneli López-Pérez
Daneli López-Pérez
TSTim Schmidt
Tim Schmidt
SKSamadhi C. Kulathunga
Samadhi C. Kulathunga
CSCynthia V. Stauffacher
Cynthia V. Stauffacher
HMG-CoA reductase (HMGR), a rate-limiting enzyme of the mevalonate pathway in Gram-positive pathogenic bacteria, is an attractive target for development of novel antibiotics. In this study, we report the crystal structures of HMGR from Enterococcus faecalis (efHMGR) in the apo and liganded forms, highlighting several unique features of this enzyme. Statins, which inhibit the human enzyme with nanomolar affinity, perform poorly against the bacterial HMGR homologs. We also report a potent competitive inhibitor (Chembridge2 ID 7828315 or compound 315) of the efHMGR enzyme identified by a high-throughput, in-vitro screening. The X-ray crystal structure of efHMGR in complex with 315 was determined to 1.27 Å resolution revealing that the inhibitor occupies the mevalonate-binding site and interacts with several key active site residues conserved among bacterial homologs. Importantly, 315 does not inhibit the human HMGR. Our identification of a selective, non-statin inhibitor of bacterial HMG-CoA reductases will be instrumental in lead optimization and development of novel antibacterial drug candidates.

1 April 2021 in Chemical Science
Verified
Journal Article
Open access
PDF file
TQTaylor R. Quinn
Taylor R. Quinn
CSCalvin N. Steussy
Calvin N. Steussy
BHBrandon E. Haines
Brandon E. Haines
JLJinping Lei
Jinping Lei
WWWei Wang
Wei Wang
OWOlaf Wiest
Olaf Wiest
Understanding the mechanisms of enzymatic catalysis requires a detailed understanding of the complex interplay of structure and dynamics of large systems that is a challenge for both experimental and computational approaches. More importantly, the computational demands of QM/MM simulations mean that the dynamics of the reaction can only be considered on a timescale of nanoseconds even though the conformational changes needed to reach the catalytically active state happen on a much slower timescale. Here we demonstrate an alternative approach that uses transition state force fields (TSFFs) derived by the quantum-guided molecular mechanics (Q2MM) method that provides a consistent treatment of the entire system at the classical molecular mechanics level and allows simulations at the microsecond timescale. Application of this approach to the second hydride transfer transition state of HMG-CoA reductase from Pseudomonas mevalonii (PmHMGR) identified three remote residues, R396, E399 and L407, (15–27 Å away from the active site) that have a remote dynamic effect on enzyme activity. The predictions were subsequently validated experimentally via site-directed mutagenesis. These results show that microsecond timescale MD simulations of transition states are possible and can predict rather than just rationalize remote allosteric residues.